A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
Conditions
Small Cell Lung Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Southern Cancer Center, Daphne, Alabama, United States
The Oncology Institute of Hope and Innovation, Long Beach, California, United States
Rocky Mountain Cancer Centers, Lone Tree, Colorado, United States
Georgetown Lombardi Cancer Center, Washington D.C., District of Columbia, United States
Clermont Oncology Center, Clermont, Florida, United States
The Oncology Institute of Hope and Innovation, Fort Lauderdale, Florida, United States
Moffitt Cancer Center, Tampa, Florida, United States
Illinois Cancer Specialists, Niles, Illinois, United States
Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, United States
University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, United States
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Henry Ford Hospital, Detroit, Michigan, United States
Minnesota Oncology Hematology, Burnsville, Minnesota, United States
Nebraska Cancer Specialists, Grand Island, Nebraska, United States
Oncology Hematology Care Clinical Trials, Cincinnati, Ohio, United States
University Hospital - Cleveland Medical Center, Cleveland, Ohio, United States
Cleveland Clinic, Cleveland, Ohio, United States
Zangmeister Cancer Center, Columbus, Ohio, United States
Oncology Associates of Oregon, Eugene, Oregon, United States
UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
Medical University of South Carolina Hollings Cancer Center, Charleston, South Carolina, United States
SCRI Oncology Partners, Nashville, Tennessee, United States
Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, Texas, United States
University of Texas Southwestern Medical Center, Dallas, Texas, United States
Oncology & Hematology Associates of Southwest Virginia, Blacksburg, Virginia, United States
Universtity of Virginia Health System, Charlottesville, Virginia, United States
Virginia Cancer Specialists Research Institute, Fairfax, Virginia, United States
Northwest Cancer Specialists, Vancouver, Washington, United States
Marshfield Medical Center, Marshfield, Wisconsin, United States
Study leads
Chief Scientific Officer
Study Director
Puma Biotechnology, Inc.